Physician profile
Robert D Fechtner
NPI 1871527259
$324,092.61
in general payments reported to CMS, 2019-2025
13 companies · $1,013 in 2025
The $1,013 reported for 2025 was more than what 77% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $133K · 2020: $51K · 2021: $85K · 2022: $27K · 2023: $14K · 2024: $12K · 2025: $1,013.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $23K · Travel and Lodging: $2,725 · Food and Beverage: $1,150 · Honoraria: $800.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $23,058.75 |
| Travel and Lodging | $2,724.56 |
| Food and Beverage | $1,150.41 |
| Honoraria | $800.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerie Pharmaceuticals, INC. | $240,606.11 | 2019-2021 | |
| Alcon Vision LLC | $53,736.26 | 2019-2025 | Hydrus Microstent, Rhopressa, Rocklatan |
| Glaukos Corporation | $7,207.96 | 2019-2022 | |
| Carl Zeiss Meditec, INC. | $6,506.73 | 2019-2023 | Cirrus Hd-Oct, Iolmaster 700, Visumax |
| Akorn, INC. | $6,500.00 | 2020 | |
| Alcon Research LLC | $4,275.00 | 2019 | |
| New World Medical,INC. | $2,821.43 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $884.15 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $800.00 | 2025 | |
| Sight Sciences, INC. | $329.84 | 2021-2022 | |
| Allergan, INC. | $229.09 | 2019-2020 | |
| Intersect Ent, INC. | $137.52 | 2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $58.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Fechtner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.